학술논문
Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Long-term quality of life analysis results of the EORTC 1325-MG/Keynote-054 double-blinded phase III trial
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041